BABA vs REBN

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.

REBN exhibits critical financial instability, characterized by a Piotroski F-Score of 4/9 and the absence of a calculable Altman Z-Score or Graham Number due to negative equity. The company is facing a severe liquidity crisis with a current ratio of 0.08, indicating an inability to meet short-term obligations. While gross margins are healthy at 55.51%, massive operating losses (-224.67% margin) and negative book value (P/B -4.66) suggest a high risk of insolvency. Recent short-term price gains appear speculative and are not supported by fundamental improvements.